Edition:
United Kingdom

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

4.31USD
20 Apr 2018
Change (% chg)

$0.03 (+0.70%)
Prev Close
$4.28
Open
$4.25
Day's High
$4.37
Day's Low
$4.25
Volume
225,801
Avg. Vol
372,899
52-wk High
$7.88
52-wk Low
$3.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 1.60 -0.130
Sep '17 1.60 -0.125
Jun '17 1.60 -0.131
Mar '17 1.60 -0.150
FY 2016 Dec '16 1.60 -0.113
Sep '16 1.60 -0.111
Jun '16 1.70 -1.006
Mar '16 1.97 -0.092
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 6 1.50 2.00 0.75 1.11
Quarter Ending Sep-18 6 1.50 2.00 0.75 1.11
Year Ending Dec-18 6 5.67 6.40 3.00 7.39
Year Ending Dec-19 4 6.30 6.40 6.00 117.15
Earnings (per share)
Quarter Ending Jun-18 6 -0.13 -0.10 -0.15 -0.19
Quarter Ending Sep-18 6 -0.14 -0.10 -0.16 -0.19
Year Ending Dec-18 6 -0.54 -0.39 -0.62 -0.64
Year Ending Dec-19 5 -0.55 -0.31 -0.74 -0.30
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.18 45.72
P/E Low - Last 5 Yrs. -- 91.59 24.22
Beta 1.54 0.90 0.88
Price to Sales (TTM) 139.32 110.89 5.71
Price to Book (MRQ) -- 13.58 5.37
Price to Tangible Book (MRQ) 12.72 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 54.51 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.89 399.08 9.21
Sales (TTM) vs TTM 1 Yr. Ago -14.29 78.82 5.69
Sales - 5 Yr. Growth Rate 59.39 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.01 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago 61.51 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate -13.77 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 7.83 5.30 2.98
LT Debt to Equity (MRQ) 0.00 22.96 12.18
Total Debt to Equity (MRQ) 0.00 24.62 16.45
Interest Coverage (TTM) -- -99.35 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -762.28 -- --
EBITD - 5 Yr. Avg -3,432.75 -574.75 10.96
Operating Margin (TTM) -767.01 -718.53 4.73
Operating Margin - 5 Yr. Avg. -3,450.43 -596.06 6.40
Pre-Tax Margin (TTM) -789.28 -693.00 5.57
Pre-Tax Margin - 5 Yr. Avg. -3,320.66 -599.42 6.81
Net Profit Margin (TTM) -789.28 -694.22 1.87
Net Profit Margin - 5 Yr. Avg. -3,320.66 -602.27 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 177,472 22,626,821 846,830,978
Net Income/Employee (TTM) -1,400,750 2,971,371 99,616,195
Receivable Turnover (TTM) 216.58 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.05 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.58 -1.11 10.95
Return on Assets - 5 Yr. Avg. -101.96 -0.57 12.31
Return on Investment (TTM) -45.27 1.58 14.38
Return on Investment - 5 Yr. Avg. -120.26 2.21 16.10
Return on Equity (TTM) -- 2.41 16.07
Return on Equity - 5 Yr. Avg. -220.88 3.09 17.39
  1 Year 3 Year 5 Year
Sales % 58.38 104.69 59.39
EPS (TTM) % -38.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ZIOPHARM Oncology Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 42.61%
# of Holders: 176
Total Shares Held: 60,674,139
3 Mo. Net Change: 1,972
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 8
# Reduced Positions: 9
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.